Drug profile · INN
stiripentol
DIACOMIT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
stiripentol (DIACOMIT) is an FDA-listed pharmaceutical active ingredient. Associated with Chiesi Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN stiripentol
Brand DIACOMIT
Route ORAL
Formulation CAPSULE
ATC code N03AX17
Originator Chiesi Australia Pty Ltd
Frequently asked questions
What is stiripentol?
stiripentol (DIACOMIT) is an FDA-listed pharmaceutical active ingredient. Associated with Chiesi Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for stiripentol?
DIACOMIT is a marketed brand name for stiripentol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of stiripentol?
stiripentol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.